June 2013

Editorial Board
Published in issue: June 2013
i

Contents
Published in issue: June 2013
ii-iv

Editorial

The importance of pharmacokinetic studies in drug development
• David F. Archer
Published online: April 22, 2013
p701-702

ARHP Commentary-Thinking (Re)Productively

Social marketing of emergency contraception: Are we missing a valuable opportunity?
• Elizabeth Westley,
• Tara Shochet
Published online: March 20, 2013
p703-705

Review Articles

Ethinyl estradiol and 17��-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment
• Frank Z. Stanczyk,
• David F. Archer,
• Bhagu R. Bhavnani
Published online: January 10, 2013
p706-727
Controversies in family planning: management of second-trimester losses in the setting of an abdominal cerclage
• Angela Martin,
• Eva Lathrop
Published online: October 12, 2012
p728-731

Original Research Articles

Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives
• Heather Fels,
• Rachel Steward,
• Alexander Melamed,
• Anna Granat,
• Frank Z. Stanczyk,
• Daniel R. Mishell Jr.
Published online: December 20, 2012
p732-737

Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics
• Andrea Thurman,
• Thomas Kimble,
• Peter Hall,
• Jill L. Schwartz,
• David F. Archer
Published online: December 26, 2012
p738-743

Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patch
• Frank Z. Stanczyk,
• David F. Archer,
• Arkady Rubin,
• Marie Foegh
Published online: December 10, 2012
p744-749

Pharmacokinetic study of single and multiple oral administrations of 2 mg dienogest in healthy Korean women
• Donghoon Shin,
• SeungHwan Lee,
• Kyoung Soo Lim,
• ...
• Sang-Goo Shin,
• In-Jin Jang,
• Kyung-Sang Yu
Published online: December 06, 2012
p750-755

Effectiveness of an optimized benzalkonium chloride gel as vaginal contraceptive: a randomized controlled trial among Chinese women
• Weihua Li,
• Zirong Huang,
• Yu Wu,
• ...
• Zhiqin Xiao,
• Xuncheng Ding,
• Jinxun Xu
Published online: October 22, 2012
p756-765

Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium
• Silvio Antonio Franceschini,
• Carolina Sales Vieira,
• Wellington P. Martins,
• Jana��na Boldrini Fran��a,
• Rui Alberto Ferriani
Published online: October 29, 2012
p766-772

Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250-mcg norgestimate and 35-mcg ethinyl estradiol
• Sigrid Nyberg
Published online: November 02, 2012
p773-781
The use of dual or two methods for pregnancy and HIV prevention amongst 18���24-year-olds in a cross-sectional study conducted in South Africa
• Lebogang Seutlwadi,
• Karl Peltzer
Published online: November 02, 2012
p782-789

Relevance of serum copper elevation induced by oral contraceptives: a meta-analysis
• ��eljka Babi��,
• Blanka Tariba,
• Jelena Kova��i��,
• Alica Pizent,
• Veda M. Varnai,
• Jelena Macan
Published online: November 15, 2012
p790-800

Is lipid profile determination necessary in women wishing to use oral contraceptives?
• Rog��rio Bonassi Machado,
• Carine Rejane Bernardes,
• Isadora Matias de Souza,
• Narayana Santana,
• Mariana Morimoto
Published online: December 14, 2012
p801-805
Gender, relationship type and contraceptive use at first intercourse
• Larry Gibbs
Published online: November 09, 2012
p806-812

The LIF receptor antagonist PEGLA is effectively delivered to the uterine endometrium and blocks LIF activity in cynomolgus monkeys
• Lindsey C. Aschenbach,
• Kim E. Hester,
• Nicole C. McCann,
• Jian-Guo Zhang,
• Evdokia Dimitriadis,
• Diane M. Duffy
Published online: November 02, 2012
p813-823
Women's information-seeking behavior after receiving contraceptive versus noncontraceptive prescriptions
• Jennefer A. Russo,
• Sara M. Parisi,
• Kathryn Kukla,
• E. Bimla Schwarz
Published online: November 02, 2012
p824-829

Optimal methods for collecting and storing vaginal specimens for prostate-specific antigen testing in research studies
• Maria F. Gallo,
• Margaret C. Snead,
• Carolyn M. Black,
• ...
• Marion Carter,
• Ana Penman-Aguilar,
• Maurizio Macaluso
Published online: November 02, 2012
p830-835

The effect of immediate postpartum depot medroxyprogesterone on early breastfeeding cessation
• Elizabeth A. Brownell,
• I. Diana Fernandez,
• Susan G. Fisher,
• ...
• Ruth A. Lawrence,
• Joseph W. Duckett,
• Ann M. Dozier
Published online: November 14, 2012
p836-843

Low-dose mifepristone increases uterine expression of aquaporin 1/aquaporin 2 at the time of implantation
• Feng Zhou,
• Yun Liang,
• Zhi-Da Qian,
• ...
• Cai-Yun Zhou,
• Xiao-Duan Chen,
• Li-Li Huang
Published online: November 02, 2012
p844-849
Calculating contraceptive decisions while intoxicated
• Julie Fennell
Published online: November 14, 2012
p850-854
Effectiveness of early medical abortion using low-dose mifepristone and buccal misoprostol in women with no defined intrauterine gestational sac
• Philip Goldstone,
• Jill Michelson,
• Eve Williamson
Published online: November 19, 2012
p855-858
Asking for what she needs? Pregnancy testing or EC?
• Jessica K. Lee,
• Sara M. Parisi,
• Erin Baldauf,
• Rachel B. Rapkin,
• Glenn M. Updike,
• Eleanor B. Schwarz
Published online: December 06, 2012
p859-863

Letter to the Editor

Re: ���Is lipid profile determination necessary in women wishing to use oral contraceptives?��� by Machado RB et al.
• Luis Bahamondes
Published online: January 14, 2013
p864

Thanks to reviewers
Published online: May 01, 2013
p865-866